GlassScriptPhysician profile
Kimberly K Burk
NPI 1588335756
$26,878.22
in general payments reported to CMS, 2019-2025
33 companies · $19K in 2025
The $19K reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,796 · 2023: $2,224 · 2024: $3,636 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Food and Beverage: $11K · Travel and Lodging: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,062.50 |
| Food and Beverage | $10,780.18 |
| Travel and Lodging | $239.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17,507.02 | 2022-2025 | |
| Livanova USA, INC. | $2,373.00 | 2022-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Eisai INC. | $875.95 | 2023-2025 | |
| Ucb, INC. | $875.31 | 2023-2025 | Briviact, Fintepla, Nayzilam |
| Pfizer INC. | $728.84 | 2023-2025 | |
| Lundbeck LLC | $597.80 | 2023-2025 | Vyepti |
| Teva Pharmaceuticals USA, INC. | $561.98 | 2023-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Alexion Pharmaceuticals, INC. | $526.82 | 2022-2025 | Ultomiris |
| Catalyst Pharmaceuticals, INC. | $455.78 | 2023-2025 | Fycompa |
| Neurelis, INC. | $366.20 | 2023-2025 | Valtoco |
| Jazz Pharmaceuticals INC. | $299.40 | 2023-2025 | |
| Lilly USA, LLC | $291.63 | 2024-2025 | Kisunla, Amyvid, Emgality |
| Sk Life Science, INC. | $268.52 | 2023-2025 | |
| Amgen INC. | $165.78 | 2022-2025 | Uplizna |
| Argenx US, INC. | $136.55 | 2025 | Vyvgart Hytrulo |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $115.70 | 2025 | Symbravo |
| Sumitomo Pharma America, INC. | $115.41 | 2023-2024 | Aptiom |
| Novartis Pharmaceuticals Corporation | $108.61 | 2024-2025 | |
| Genentech USA, INC. | $70.02 | 2024-2025 | Ocrevus, Ocrevus Zunovo |
| Tg Therapeutics, INC. | $69.14 | 2025 | |
| Acadia Pharmaceuticals INC | $65.13 | 2023-2025 | Nuplazid |
| Mallinckrodt Hospital Products INC. | $49.24 | 2025 | Acthar |
| Kyowa Kirin, INC. | $42.27 | 2023 | Nourianz |
| Takeda Pharmaceuticals U.S.A., INC. | $27.90 | 2024 | Hyqvia |
| Neurocrine Biosciences, INC. | $26.63 | 2025 | |
| Servier Pharmaceuticals LLC | $24.27 | 2025 | |
| Medtronic, INC. | $23.23 | 2024 | Linq II |
| Celgene Corporation | $22.94 | 2025 | Zeposia |
| Baxter Healthcare | $22.03 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Biogen, INC. | $19.90 | 2025 | Vumerity |
| Cala Health, INC. | $19.43 | 2025 | Cala Kiq |
| Impel Pharmaceuticals INC. | $16.92 | 2023 | Trudhesa |
| Aucta Pharmaceuticals, INC. | $8.87 | 2024 | Motpoly Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Burk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.